Read also: ‘It’s for humanity’: Indonesians step up to volunteer in vaccine trialsAirlangga University rector M. Nasih previously touted the potential drug in development as “the first COVID-19 cure” in the world. It contained combinations of existing medicines, namely lopinavir/ritonavir and azithromycin, lopinavir/ritonavir and doxycycline and hydroxychloroquine and azithromycin.Health experts, however, urged the public not to get their hopes up, as the three combinations had been included on the list of potential COVID-19 remedies undergoing clinical trials initiated by the World Health Organization (WHO).While the research team had not responded to the BPOM’s report, Penny said Army chief of staff Gen. Andika Perkasa had acknowledged the agency’s findings as he supported efforts to continue clinical trials and ensure the drugs’ efficacy.Separately, BIN’s deputy head of communication and information, Wawan Hari Purwanto, said the research and development team was committed to following up on the BPOM’s recommendation.“We have yet to convey any new development because we need time to make the required corrections,” Wawan said on Wednesday. “We are always in touch [with the BPOM] because we cannot proceed to the next stages if we do not fulfill their requirements.”The research team hoped to finish the drug as soon as possible in accordance with existing protocols.Penny added that it was common for drug research to receive corrections from the BPOM before it passed and received the distribution license.Topics : “The research needs to be conducted at random to better represent the Indonesian population,” Penny said Wednesday.The tested drug was also administered to COVID-19 asymptomatic patients, whereas the BPOM’s protocol stated that tested drugs should be given to patients with mild, moderate and severe symptoms.Penny added that the trial showed no significant results, with the drug’s effects being similar to existing remedies used to treat COVID-19 patients.The BPOM also called for the researchers to note possible side effects in future tests, given that the drug contained combinations of a number of potent medications. The Food and Drug Monitoring Agency (BPOM) has said potential COVID-19 remedies being developed by Airlangga University in Surabaya, East Java, require additional clinical trials.BPOM head Penny Kusumawati Lukito said that upon inspecting the clinical trial of the drug — developed in collaboration with the Indonesian Army and the State Intelligence Agency (BIN) — on July 28, the agency found several critical findings that affected the test’s validity.According to the agency, the clinical trials had not fulfilled the BPOM’s protocols in randomizing the test subjects, including symptom severity variations.
16 Elizabeth St, Currumbin Waters.More from news02:37Purchasers snap up every residence in the $40 million Siarn Palm Beach Northless than 1 hour ago02:37International architect Desmond Brooks selling luxury beach villa21 hours ago“We had six registered bidders and three active bidders he said.“Bidding open at $850,000 before it sold to a family for $910,000.”He said the house offered an exceptional lifestyle in popular Currumbin Waters.“It was a well designed and well thought-out renovation,” he said.“There is nothing left to do but move in and enjoy the property.” 16 Elizabeth St, Currumbin Waters.A QUINTESSENTIAL Gold Coast beach house “superbly renovated” sold under the hammer over the weekend for $910,000.The property at 16 Elizabeth St, Currumbin Waters pulled a crowd of about 40 people according to agent Billy Jaz of McGrath Palm Beach. 16 Elizabeth St, Currumbin Waters. 16 Elizabeth St, Currumbin Waters.On the southern border with New South Wales and set back from the ocean, Currumbin Waters is comprised of affordable residential pockets as well as some industrial property.The relaxed lifestyle and convenient location of the suburb has placed it in high demand with house hunters. CoreLogic data shows house prices in Currumbin Waters have jumped 45 per cent to $654,000 over the five years to September, 2017.